Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Indian Council of Medical Research's network of pulmonary fibrosis (INPF): A big step forward towards understanding interstitial lung diseases in India.

Lung India : official organ of Indian Chest Society·2026
Same author

Prolonged Invasive Mechanical Ventilation in a Tertiary Respiratory ICU: Outcomes, Challenges, and Future Directions.

Cureus·2026
Same author

A young male with dyspnoea after placement of a pleural drain.

The National medical journal of India·2026
Same author

The mystery of migrating pleural effusion: Diagnosing the improbable.

Tropical parasitology·2026
Same author

Tetrahymena as a model organism for cilia research.

Seminars in cell & developmental biology·2026
Same author

Phenotyping and unmet need assessment for biological agents in uncontrolled asthma.

Lung India : official organ of Indian Chest Society·2026

Related Experiment Video

Updated: Jul 3, 2026

Conducting Respiratory Oscillometry in an Outpatient Setting
14:49

Conducting Respiratory Oscillometry in an Outpatient Setting

Published on: April 8, 2022

Spirometry after treatment completion for pulmonary tuberculosis - a necessity?

Siddhartha Chakraborty1, T Ajai Kumar1, Rahul Tyagi1

  • 1Department of Pulmonary Medicine, Critical Care and Sleep Medicine, Army Institute of Cardio-Thoracic Sciences, Pune.

Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace
|July 2, 2026
PubMed
Summary

Even after a tuberculosis cure, lung damage is common, leading to lasting respiratory problems. Routine lung function tests are crucial to detect and manage this post-tuberculosis lung disease.

Keywords:
Pulmonary tuberculosisairflow obstructionpost-tuberculosis lung diseasepulmonary rehabilitationrestrictive spirometry patternspirometry

Related Experiment Videos

Last Updated: Jul 3, 2026

Conducting Respiratory Oscillometry in an Outpatient Setting
14:49

Conducting Respiratory Oscillometry in an Outpatient Setting

Published on: April 8, 2022

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Radiology

Background:

  • Pulmonary tuberculosis frequently causes irreversible lung damage like fibrosis and bronchiectasis.
  • This structural damage can lead to post-tuberculosis lung disease (PTLD), characterized by chronic respiratory symptoms and reduced lung function.
  • Microbiological cure of tuberculosis does not guarantee full recovery of respiratory health.

Purpose of the Study:

  • To assess the prevalence and nature of functional and radiological impairments in patients post-anti-tubercular therapy.
  • To understand the long-term respiratory health impact of tuberculosis.
  • To identify predictors of lung damage after tuberculosis treatment.

Main Methods:

  • A prospective study involving 175 adult patients within one year of completing anti-tubercular therapy.
  • Evaluation included spirometry to assess lung function and radiological assessments for structural damage.
  • Analysis correlated baseline sputum smear status with observed impairments.

Main Results:

  • Spirometric abnormalities were found in 57.1% of participants.
  • Restrictive lung patterns were most common (30.3%), followed by obstructive defects (16.6%) and Preserved Ratio Impaired Spirometry (PRISm) (10.3%).
  • Sputum smear positivity at diagnosis was a strong predictor of obstructive disease and severe structural damage, even in young, non-smoking individuals.

Conclusions:

  • Post-tuberculosis lung disease is prevalent and often irreversible, affecting respiratory health despite microbiological cure.
  • Current assessment at treatment completion is insufficient to address long-term respiratory morbidity.
  • Routine spirometry and comprehensive respiratory evaluation are recommended at the end of tuberculosis treatment to manage PTLD.